 Now, the chief medical officer of the Mashantucket Pequot Tribal Nation is at the helm of a project to address the problem. Mashantucket Pequot has received $2.4 million from the U.S. Economic Development Administration for a two-year feasibility study into creating a business plan to manufacture generic pharmaceutical drugs on tribal land.